Quest Diagnostics Q3 revenue beats; raises 2026 revenue forecast
DGX•Quest Diagnostics reported third-quarter revenue of $3.10 billion and adjusted EPS of $3, beating analyst expectations, and raised its 2026 revenue and EPS forecasts.
1. Quarterly results
Third-quarter revenue grew 10% year over year to $3.10 billion, above the $3.05 billion consensus estimate. Adjusted EPS rose 15.4% to $3, beating the $2.86 estimate; reported EPS was $2.78 and net income was $312 million.
2. Raised 2026 forecast
Quest Diagnostics raised its 2026 revenue guidance to $12.065 billion-$12.105 billion. It now expects reported diluted EPS of $10.21-$10.31 and adjusted diluted EPS of $11.25-$11.35.
3. Growth drivers
The company said strong performance across physician, hospital and consumer channels drove results. It attributed organic revenue growth to aging-population care needs and increased focus on prevention and wellness, while CEO Jim Davis said automation and AI productivity gains contributed.
